Malesci Alberto DocenteMedicineProfessore Straordinario - MED/12

Alberto Malesci is Professor of Gastroenterology at San Raffaele University and Senior Consultant of the Division of Gastroenterology at San Raffaele Hospital in Milan.

After graduating in Medicine in 1975, he obtained board certifications in Gastroenterology and Internal Medicine.
The academic career of professor Malesci started with a fellowship in the lab of dr. Rosalyn Yalow, 1977 Nobel Laureate for Medicine, at the Bronx VA Medical Centre-Mount Sinai School of Medicine of New York, where he conducted pioneeristic studies on gastrointestinal hormones.
From 1980 to 2018, he was Professor of Internal Medicine and Gastroenterology at Milan University.
From 2018 to 2022, he was affiliated to Humanitas University as Professor of Internal Medicine and Director of the Internal Medicine Residency Program. Previous clinical positions of Professor Malesci include the role of Staff Physician at the Ospedale Maggiore Policlinico of Milan (from 1980 to 1996) and the lead of the Department of Gastroenterology of Humanitas Research Hospital from 1996 to 2022. Under his guidance, that Department gained worldwide recognition as a clinical and academic excellence in Gastroenterology, particularly in the fields of colorectal and pancreatic neoplasia, inflammatory bowel disease and interventional endoscopy.
In the ’80s and in the ‘90s, the research activity of Professor Malesci focused on gastrointestinal pathophysiology and on biochemical diagnosis of pancreatic diseases. A major scientific achievement of that period was the development and the clinical validation of serum CA19-9 as a biomarker for diagnosis and follow-up of pancreatic cancer.
More recently, the field of research interest extended to the characterization of molecular subtypes and to the development of prognostic and predictive biomarkers for colorectal cancer. In this context, he has contributed highly-cited papers on the role of tumor-associated lymphocytes and macrophages in predicting colorectal cancer progression and response to chemotherapy. Professor Malesci published over 200 Medline-indexed papers, scoring a h-index of 60 in Google Scholar and of 50 in Scopus

(Update apr. 2022)